Comparing the effects of statins and ARBs on rheumatoid arthritis
Investigational and Comparative Study Between the Anti-inflammatory Effectof Both Angiotensin Reeptor Blockers and Statins on Rheumatoid Arthritis Disease Activity on Egyptian Patients
This study is testing whether statins or angiotensin receptor blockers (ARBs) can better reduce inflammation and improve symptoms in people with rheumatoid arthritis.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 45 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Trial ID | NCT03770702 on ClinicalTrials.gov |
What this trial studies
This study investigates the anti-inflammatory effects of angiotensin receptor blockers (ARBs) and statins on disease activity in patients with rheumatoid arthritis. It is a Phase 3 interventional trial conducted in Egypt, focusing on comparing the efficacy of these two classes of medications. The study aims to provide insights into how these treatments can influence the management of rheumatoid arthritis symptoms and overall patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals diagnosed with rheumatoid arthritis.
Not a fit: Patients who are pregnant, lactating, or have hepatic or renal impairment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients with rheumatoid arthritis.
How similar studies have performed: There is limited information on the success of similar studies, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Rheumatoid arthritis. Exclusion Criteria: * Pregnant or lactating * Hepatic or renal impairment.
Where this trial is running
Tanta
- Sherief Abd-Elsalam — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: Sahar K Hegazy, Prof — Head of Clinical Pharmacy Department
- Study coordinator: Sherief Abd-Elsalam, Ph D
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.